Testicular Germ Cell Tumors Acquire Cisplatin Resistance by Rebalancing the Usage of DNA Repair Pathways
出版年份 2021 全文链接
标题
Testicular Germ Cell Tumors Acquire Cisplatin Resistance by Rebalancing the Usage of DNA Repair Pathways
作者
关键词
-
出版物
Cancers
Volume 13, Issue 4, Pages 787
出版商
MDPI AG
发表日期
2021-02-14
DOI
10.3390/cancers13040787
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Olaparib as salvage treatment for advanced germ cell tumors after chemotherapy failure: Results of the open-label, single-arm, IGG-02 phase II trial.
- (2020) Ugo De Giorgi et al. JOURNAL OF CLINICAL ONCOLOGY
- Suppression of non-homologous end joining does not rescue DNA repair defects in Fanconi anemia patient cells
- (2020) Supawat Thongthip et al. CELL CYCLE
- Inactivation of DNA-PK by knockdown DNA-PKcs or NU7441 impairs non-homologous end-joining of radiation-induced double strand break repair
- (2018) Jun Dong et al. ONCOLOGY REPORTS
- Integrated Molecular Characterization of Testicular Germ Cell Tumors
- (2018) Hui Shen et al. Cell Reports
- Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy
- (2018) Michael Friedlander et al. BRITISH JOURNAL OF CANCER
- BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance
- (2018) Joseph Nacson et al. Cell Reports
- Non-homologous DNA end joining and alternative pathways to double-strand break repair
- (2017) Howard H. Y. Chang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Reduced recruitment of 53BP1 during interstrand crosslink repair is associated with genetically inherited attenuation of mitomycin C sensitivity in a family with Fanconi anemia
- (2017) Emilie Lesport et al. Oncotarget
- Interplay between Fanconi anemia and homologous recombination pathways in genome integrity
- (2016) Johanna Michl et al. EMBO JOURNAL
- The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel
- (2016) Sean R Williamson et al. HISTOPATHOLOGY
- 53BP1 fosters fidelity of homology-directed DNA repair
- (2016) Fena Ochs et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells
- (2016) Shuhei Ito et al. PLoS One
- 53BP1 fosters fidelity of homology-directed DNA repair
- (2016) Fena Ochs et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The PDGFRβ–AKT Pathway Contributes to CDDP-Acquired Resistance in Testicular Germ Cell Tumors
- (2013) M. Juliachs et al. CLINICAL CANCER RESEARCH
- International Variations and Trends in Testicular Cancer Incidence and Mortality
- (2013) Ariana Znaor et al. EUROPEAN UROLOGY
- Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors
- (2013) Francesca Cavallo et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- A Cell Cycle-Dependent Regulatory Circuit Composed of 53BP1-RIF1 and BRCA1-CtIP Controls DNA Repair Pathway Choice
- (2013) Cristina Escribano-Díaz et al. MOLECULAR CELL
- Co-operation of BRCA1 and POH1 relieves the barriers posed by 53BP1 and RAP80 to resection
- (2013) Andreas Kakarougkas et al. NUCLEIC ACIDS RESEARCH
- 53BP1 Regulates DSB Repair Using Rif1 to Control 5' End Resection
- (2013) M. Zimmermann et al. SCIENCE
- Repair of Strand Breaks by Homologous Recombination
- (2013) M. Jasin et al. Cold Spring Harbor Perspectives in Biology
- Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
- (2012) J. Ross Chapman et al. MOLECULAR CELL
- BRCA1 Functions Independently of Homologous Recombination in DNA Interstrand Crosslink Repair
- (2012) Samuel F. Bunting et al. MOLECULAR CELL
- Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition
- (2012) Francesca Cavallo et al. PLoS One
- Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
- (2011) K. Oechsle et al. ANNALS OF ONCOLOGY
- Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers
- (2011) Marieke A. Vollebergh et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Homology-directed Fanconi anemia pathway cross-link repair is dependent on DNA replication
- (2011) Koji Nakanishi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
- (2010) Samuel F. Bunting et al. CELL
- Preventing Nonhomologous End Joining Suppresses DNA Repair Defects of Fanconi Anemia
- (2010) Adele Adamo et al. MOLECULAR CELL
- Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells
- (2010) M. Fenech et al. MUTAGENESIS
- Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130
- (2010) D. C. Hegan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2
- (2009) Andrea Beucher et al. EMBO JOURNAL
- Mechanism of Replication-Coupled DNA Interstrand Crosslink Repair
- (2008) Markus Räschle et al. CELL
- Alternative-NHEJ Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break Repair
- (2008) Nicole Bennardo et al. PLoS Genetics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started